Aditi Deshmukh currently serves as a Research Associate II at Zymeworks Inc. since August 2023. Prior experience includes working as a Research and Development Officer at Gennova Biopharmaceuticals from January 2021 to November 2022, where Aditi conducted T-cell and B-cell assays to evaluate cellular responses during India’s first mRNA-based COVID-19 vaccine trials, independently compiling and analyzing flow cytometry data for all trial phases. Aditi began as a Research Intern at Gennova Biopharmaceuticals, performing assays on pre-clinical samples from mice immunized with the mRNA vaccine. Aditi holds a Master of Science in Neurochemistry with molecular neurobiology from Stockholm University and a Master of Science in Biochemistry from Maharaja Sayajirao University of Baroda. The educational background also includes a Bachelor of Science in Biotechnology from Savitribai Phule Pune University.
Links
This person is not in any teams
This person is not in any offices